India:
Bombay HC Dismisses Challenge To Nexavar Compulsory License
15 October 2014
S&A Law Offices
To print this article, all you need is to be registered or login on Mondaq.com.
Recently The Bombay high court dismissed a challenge by Bayer AG
against a decision to allow drug maker Natco Pharma Ltd to
manufacture and sell a generic copy of a patent-protected cancer
drug made by the German company. The court was hearing a plea filed
by Bayer challenging a March 2013 order passed by the Intellectual
Property Appellate Board (IPAB) permitting Hyderabad-based Natco
Pharma to manufacture and sell a generic copy of the patented drug
Nexavar.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from India
Legal Implications Of AI-Created Works In India
Khurana and Khurana
AI has become a buzzword in our lives, considering its role and impact. It has its pros and cons that is to be governed by law and order. This Blog delves into these issues, exploring AI's potential and future, especially in the context of Indian laws.
What Is Fair Use Of Copyright Doctrine?
Photon legal
Have you ever used a copyrighted work without permission, and wondered whether it was legal or not? You might have heard of the term "fair use," but what exactly does it mean?
An Overview Of Evergreening Patents
Photon legal
Do you know that there's a way to evergreen your patents? Evergreen, as the name suggests, is something that will last for a lifetime. Therefore, Evergreening of patents is a process...